levodopa has been researched along with methyldopa in 130 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 76 (58.46) | 18.7374 |
1990's | 19 (14.62) | 18.2507 |
2000's | 18 (13.85) | 29.6817 |
2010's | 17 (13.08) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ax, F; Bonham, NM; Hallberg, A; Karlén, A; Lennernäs, H; Winiwarter, S | 1 |
Amidon, GL; Han, HK; Hsu, CP; Oh, DM; Rhie, JK; Saito, G; Stewart, BH | 1 |
Cha, SH; Chairoungdua, A; Endou, H; Kanai, Y; Kim, DK; Matsuo, H | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Avdeef, A; Tam, KY | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Davidson, L; Hornykiewicz, O; Lloyd, KG | 1 |
Harrewijn, P | 1 |
Warchoł, JB; Zabel, M | 1 |
Bidard, JN; Cronenberger, L; Fonlupt, P; Pacheco, H | 1 |
Sternon, J | 1 |
Culvenor, AJ; Jarrott, B | 1 |
Luchins, D | 2 |
Sherman, GP; Walton, CA | 1 |
Atkinson, AR; Norris, KA; Smith, WG | 1 |
Dabagov, NS; Skoldinov, AP; Uspenskiĭ, AE | 1 |
Doyle, AE; Jarrott, B; Louis, WJ; McNeil, JJ; Vajda, FJ | 1 |
Comi, R; Fahn, S; Prasad, AL; Snider, SR | 1 |
Wick, MM | 1 |
Zabel, M | 2 |
Sjönell, G | 1 |
Clay, KL; Murphy, RC | 1 |
Duvoisin, RC; Mytilineou, C | 1 |
Feuerstein, C; Gavend, M; Pellat, J; Perret, J; Serre, F; Tanche, M | 2 |
Das Gupta, D; Ghanekar, AG | 1 |
Henocque, G; Koffi, A; Macart, M | 1 |
Ernst, AM | 1 |
Marsden, CD; Mindham, RH; Parkes, JD | 1 |
Woods, RI | 1 |
Thut, PD | 1 |
Debono, AG; Jenner, P; Parkes, JD; Walters, J | 1 |
Deruaz, D; Gjessing, L; Greffe, J; Guilluy, R; Mathieu, P | 1 |
Feigenson, JS; McDowell, FH; Sweet, RD | 1 |
Goodale, DB; Moore, KE | 1 |
Korobov, NV; Uspenskiĭ, AE | 1 |
Maître, L; Waldmeier, PC | 1 |
Katzman, R; Wade, LA | 1 |
Horie, R; Yamori, Y | 1 |
McDowell, FH; Sweet, RD | 2 |
Chibata, I; Yamada, S; Yamamoto, M | 1 |
Cheng, LK; Fung, HL | 1 |
Balestreri, R; Bertolini, S; Costa, S; Elicio, N | 1 |
Anisimov, VN | 1 |
Hodge, CJ; King, RB | 1 |
Meites, J; Riegle, GD | 1 |
Nevsímal, O; Roth, B; Vymazal, J | 1 |
Calne, DB; Fermaglich, J | 1 |
Collin, C; Eckernäs, SA; Grahnén, A; Ling-Andersson, A; Nilsson, M; Tiger, G | 1 |
Männistö, PT; Tuomainen, P; Tuominen, RK | 1 |
De Klippel, N; Deleu, D; Ebinger, G; Herregodts, P; Michotte, Y; Sarre, S | 1 |
Bałuk, P; Gabella, G | 1 |
Greene, RJ; Hall, AD; Hider, RC | 1 |
Barbier, C; Huguet, C; Robinet, D; Said, R; Sartre, J | 1 |
Medenica, M; Nikolić, K | 1 |
Davoudi, H; Durso, R; Feldman, RG; Szabo, G | 1 |
Issopoulos, PB | 1 |
Bennett, JP; Landow, E; Turk, M | 1 |
Fujimoto, H; Kawai, H; Masuda, T; Saito, S | 1 |
Bazan, E; de Yebenes, JG; Mena, MA; Muradas, V; Reiriz, J | 1 |
Nutt, JG | 1 |
Nagatsu, T; Naoi, M | 1 |
Jenner, P; Marion, MH; Marsden, CD; Quinn, NP; Stocchi, F | 1 |
Hardie, RJ; Lees, AJ; Stern, GM | 1 |
Evans, WS; Ho, KY; Thorner, MO | 1 |
Munro, HN; Roel, LE; Weiss, BF; Wurtman, RJ | 1 |
Colombo, JP; Küffer, H; Peheim, E; Richterich, R | 1 |
Antonaccio, MJ; Burrell, R; Robson, RD | 1 |
Muenter, MD; Sharpless, NS; Tyce, GM | 1 |
Andén, NE; Engel, J | 1 |
Lindén, IB | 1 |
Daniele, E; Zamboni, P | 1 |
Petz, LD | 1 |
Da Prada, M; Haefely, WE; Keller, HH; Kettler, R; Pieri, L | 1 |
Fahn, S; Reches, A | 1 |
Gelber, LR; Neumeyer, JL | 1 |
Kemi, M; Kondo, M; Maki, E; Tanabe, K | 1 |
Adam, WR; Campbell, DJ; Funder, JW; Mendelsohn, FA | 1 |
Ardaillou, R; Hagege, J; Loreau, N; Wahbe, F | 1 |
Fahn, S; Jiang, D; Reches, A | 1 |
Henning, M; Johansson, P | 1 |
Nuzhnyĭ, VP; Uspenskiĭ, AE; Zabirova, IG | 1 |
Reilly, DK; Rivera-Calimlim, L; Van Dyke, D | 1 |
Jung, MJ; Palfreyman, MG; Ribéreau-Gayon, G; Wagner, J; Zraïka, M | 1 |
Deleu, D; Ebinger, G; Michotte, Y; Sarre, S; Van Belle, K | 1 |
Carey, RJ; Huston, JP; Pinheiro-Carrera, M; Tomaz, C | 1 |
Bräutigam, K; Morgenstern, R; Sohr, R | 1 |
García Cánovas, F; García Moreno, M; Sánchez Gracia, A; Tudela, J; Varón, R | 1 |
Rausing, A; Rosén, U | 1 |
Clarke, JB; Gandolfi, AJ; Hastings, K; Hubbard, AK; Lohr, CL | 1 |
Deleu, D; Ebinger, G; Michotte, Y; Sarre, S | 1 |
Andre, MH; Bruguerolle, B; Grignon, S | 1 |
Balogh-Nemes, K; Horvai, G; Klebovich, I; Tolokán, A | 1 |
Dolezalová, M; Tkaczyková, M | 1 |
Ameyaw, MM; McLeod, HL; Ofori-Adjei, D; Syvänen, AC; Ulmanen, I | 1 |
Szakács, T; Vereczkey, L; Veres, Z | 1 |
Forsberg, M; Gogos, JA; Huotari, M; Hyttinen, J; Karayiorgou, M; Koponen, O; Männistö, PT; Raasmaja, A | 1 |
Fekete, MI; Fülöp, F; Homicskó, KG; Kertész, I; Nagy, GM; Radnai, B; Tóth, BE; Tóth, G | 1 |
Arstrand, K; Dizdar, N; Kågedal, B | 1 |
Crevoisier, C; Metzger, B; Monreal, A; Nilsen, T | 1 |
Parada, A; Soares-da-Silva, P; Vieira-Coelho, MA | 1 |
SOULAIRAC, A; SOULAIRAC, ML | 1 |
Bendsoe, N; Falck, B; Ronquist, G | 1 |
Andrews, AM; Holmes, A; Huang, SJ; Kim, DK; Lesch, KP; Martin, BJ; Murphy, DL; Tolliver, TJ; Wichems, C | 1 |
Aisen, P; Casadevall, A; Dadachova, E; Eisenman, HC; Garcia-Rivera, J; Moadel, T; Nosanchuk, JD; Zaragoza, O | 1 |
Dean, RT; Hume, PM; Morris, JG; Rodgers, KJ | 1 |
Chamsaz, M; Fadaee, J; Safavi, A | 1 |
Fu, HY; Li, SF; Li, YN; Nie, JF; Wu, HL; Yu, RQ; Yu, YJ | 1 |
Fisher, R; Jackson, MJ; Jenner, P; Rose, S; Tayarani-Binazir, KA; Zoubiane, G | 1 |
Antonini, A; Bareggi, SR; Bondiolotti, G; Natuzzi, F | 1 |
Barba, E; Bugamelli, F; Marcheselli, C; Raggi, MA | 1 |
Bengel, G; Ebersbach, G; Ehret, R; Jugel, C; Klostermann, F; Muhlack, S; Müller, T | 1 |
Bonfim, RR; Byrro, RM; Cardoso, FF; César, Ida C; da Silva, EP; Gomes, SA; Mundim, IM; Pianetti, GA; Teixeira, Lde S | 1 |
Bonfim, RR; Byrro, RM; César, IC; Gomes, SA; Mundim, IM; Pianetti, GA; Santana E Silva Cardoso, FF; Souza Teixeira, L | 1 |
Asanuma, M; Kikkawa, Y; Kimoto, N; Miyazaki, I; Miyoshi, K; Murakami, S; Takeshima, M | 1 |
Barbe, MT; Christensen, MS; Florin, E; Herz, DM; Reck, C; Siebner, HR; Timmermann, L; Tittgemeyer, M; Tscheuschler, MK | 1 |
Muhlack, S; Müller, T | 1 |
8 review(s) available for levodopa and methyldopa
Article | Year |
---|---|
Biogenic amines and affective disorders. A critical analysis.
Topics: 5-Hydroxytryptophan; Affective Symptoms; Antidepressive Agents, Tricyclic; Biogenic Amines; Bipolar Disorder; Brain Chemistry; Clinical Trials as Topic; Depression; Electroconvulsive Therapy; Fenclonine; Fusaric Acid; Humans; Levodopa; Lithium; Methyldopa; Methyltyrosines; Methysergide; Monoamine Oxidase Inhibitors; Phenylketonurias; Reserpine; Tryptophan | 1976 |
Adrenergic transmission and drug interaction.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Antidepressive Agents; Catechol O-Methyltransferase; Drug Interactions; Guanethidine; Humans; Levodopa; Methyldopa; Monoamine Oxidase Inhibitors; Neurons; Norepinephrine; Receptors, Adrenergic; Reserpine; Sympathetic Nervous System; Synaptic Transmission | 1975 |
Compulsive gnawing.
Topics: 5-Hydroxytryptophan; Animals; Apomorphine; Behavior, Animal; Benserazide; Dextroamphetamine; Dihydroxyphenylalanine; Dopamine; Iproniazid; Levodopa; Male; Methyldopa; Methyltyrosines; Rats; Serotonin; Structure-Activity Relationship; Time Factors | 1976 |
The case for and concerns about continuous dopamine stimulation in Parkinson's disease.
Topics: Administration, Oral; Animals; Delayed-Action Preparations; Dopamine; Drug Tolerance; Humans; Infusion Pumps; Levodopa; Methyldopa; Parkinson Disease; Stimulation, Chemical | 1988 |
Disorders of prolactin and growth hormone secretion.
Topics: Acromegaly; Arginine; Clonidine; Dwarfism; Female; Glucose Tolerance Test; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Hypothalamo-Hypophyseal System; Hypothyroidism; Insulin-Like Growth Factor I; Kidney Failure, Chronic; Lactation; Levodopa; Male; Methyldopa; Physical Exertion; Pituitary Neoplasms; Pregnancy; Prolactin; Propranolol; Reserpine; Sleep; Somatomedins; Thyrotropin-Releasing Hormone | 1985 |
Drug-induced immune haemolytic anaemia.
Topics: Adsorption; Anemia, Hemolytic, Autoimmune; Autoantibodies; Autoantigens; Blood Transfusion; Cephalosporins; Complement Activation; Coombs Test; Erythrocyte Aging; gamma-Globulins; Haptens; Humans; Immunity, Cellular; Levodopa; Mefenamic Acid; Methyldopa; Penicillins | 1980 |
The pharmacology of Parkinson's disease: basic aspects and recent advances.
Topics: Animals; Antiparkinson Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Brain; Bromocriptine; Carbidopa; Corpus Striatum; Dopamine; Ergolines; Humans; Kidney; Kinetics; Levodopa; Lisuride; Liver; Methyldopa; Norepinephrine; Parkinson Disease; Pergolide; Receptors, Dopamine; Selegiline; Serotonin; Stereotyped Behavior; Substantia Nigra; Tyramine | 1984 |
Is aldosterone secretion under dopaminergic control?
Topics: Aldosterone; Bromocriptine; Chlorpromazine; Dopamine; Dopamine Antagonists; Edema; Humans; Levodopa; Methyldopa; Metoclopramide; Parkinson Disease; Sulpiride | 1981 |
6 trial(s) available for levodopa and methyldopa
Article | Year |
---|---|
Biogenic amines and affective disorders. A critical analysis.
Topics: 5-Hydroxytryptophan; Affective Symptoms; Antidepressive Agents, Tricyclic; Biogenic Amines; Bipolar Disorder; Brain Chemistry; Clinical Trials as Topic; Depression; Electroconvulsive Therapy; Fenclonine; Fusaric Acid; Humans; Levodopa; Lithium; Methyldopa; Methyltyrosines; Methysergide; Monoamine Oxidase Inhibitors; Phenylketonurias; Reserpine; Tryptophan | 1976 |
The combined use of L-alpha-methyldopa hydrazine and methyldopa in the treatment of hypertension.
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrazines; Hypertension; Levodopa; Male; Methyldopa; Middle Aged; Placebos; Time Factors | 1978 |
Psychiatric symptoms during l-dopa therapy for Parkinson's disease and their relationship to physical disability.
Topics: Aged; Amantadine; Carbidopa; Clinical Trials as Topic; Depression; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Interview, Psychological; Levodopa; Male; Mental Status Schedule; Methyldopa; Middle Aged; Parkinson Disease; Placebos; Recurrence; Trihexyphenidyl | 1976 |
Comparative multiple-dose pharmacokinetics of controlled-release levodopa products.
Topics: Adult; Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Female; Humans; Levodopa; Male; Metabolic Clearance Rate; Methyldopa; Neurologic Examination; Parkinson Disease | 1992 |
Comparative single- and multiple-dose pharmacokinetics of levodopa and 3-O-methyldopa following a new dual-release and a conventional slow-release formulation of levodopa and benserazide in healthy volunteers.
Topics: Adult; Antiparkinson Agents; Benserazide; Biological Availability; Chromatography, High Pressure Liquid; Cross-Over Studies; Delayed-Action Preparations; Dopamine Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Female; Humans; Levodopa; Male; Methyldopa; Reference Values | 2003 |
Elevation of total homocysteine levels in patients with Parkinson's disease treated with duodenal levodopa/carbidopa gel.
Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Duodenum; Female; Gels; Homocysteine; Humans; Hyperhomocysteinemia; Levodopa; Male; Methyldopa; Middle Aged; Parkinson Disease | 2011 |
117 other study(ies) available for levodopa and methyldopa
Article | Year |
---|---|
Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach.
Topics: Humans; Intestinal Absorption; Jejunum; Models, Biological; Multivariate Analysis; Permeability; Pharmaceutical Preparations; Structure-Activity Relationship | 1998 |
CHO/hPEPT1 cells overexpressing the human peptide transporter (hPEPT1) as an alternative in vitro model for peptidomimetic drugs.
Topics: Animals; Biological Transport; Caco-2 Cells; Carrier Proteins; CHO Cells; Cricetinae; Dipeptides; Humans; Kinetics; Peptide Transporter 1; Reproducibility of Results; Symporters; Transfection | 1999 |
Expression cloning of a Na+-independent aromatic amino acid transporter with structural similarity to H+/monocarboxylate transporters.
Topics: Amino Acid Sequence; Amino Acid Transport Systems; Amino Acid Transport Systems, Neutral; Animals; Anion Transport Proteins; Bacterial Proteins; Carrier Proteins; Cloning, Molecular; Escherichia coli Proteins; Female; Intestine, Small; Kinetics; Levodopa; Mice; Molecular Sequence Data; Oocytes; Phenylalanine; Rats; Recombinant Proteins; Sequence Alignment; Sequence Homology, Amino Acid; Substrate Specificity; Tryptophan; Tyrosine; Xenopus laevis | 2001 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
The neurochemistry of Parkinson's disease: effect of L-dopa therapy.
Topics: Aged; Brain; Catechol O-Methyltransferase; Dihydroxyphenylalanine; Dopa Decarboxylase; Dopamine; Female; Homovanillic Acid; Humans; Levodopa; Male; Methyldopa; Middle Aged; Monoamine Oxidase; Parkinson Disease; Tyrosine 3-Monooxygenase | 1975 |
Role of monoamine metabolism in wing dimorphism of the aphid Myzus persicae.
Topics: Animals; Aphids; Autonomic Agents; Dopamine; Fenclonine; Isoproterenol; Levodopa; Methyldopa; Norepinephrine; Physostigmine; Reserpine; Tryptamines; Wings, Animal | 1976 |
The effect of l-dopa and alpha-methyl-dopa on C cell secretion in the thyroid gland.
Topics: Animals; APUD Cells; Guinea Pigs; Levodopa; Methyldopa; Thyroid Gland | 1977 |
[Effect of S-adenosyl-L-methionine on the cerebral and peripheral metabolism of L-dopa].
Topics: Animals; Biological Transport; Brain; Catecholamines; Dopamine; Levodopa; Male; Methyldopa; Norepinephrine; Normetanephrine; Rats; S-Adenosylmethionine; Tissue Distribution | 1978 |
[The practitioner and drug-induced, predominantly orthostatic hypotension].
Topics: Adrenergic Agents; Adrenergic Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Antihypertensive Agents; Antipsychotic Agents; Barbiturates; Butyrophenones; Clonidine; Debrisoquin; Diazoxide; Diuretics; Ganglionic Blockers; Humans; Hydralazine; Hypotension, Orthostatic; Levodopa; Meprobamate; Methyldopa; Mineralocorticoids; Monoamine Oxidase Inhibitors; Phenothiazines; Prazosin; Psychotropic Drugs; Reserpine; Vasodilator Agents | 1978 |
Reduction in the level of immunotitratable dopamine beta-hydroxylase after chronic administration of L-dopa or alpha-methyldopa.
Topics: Adrenal Glands; Amino Acids; Animals; Carboxy-Lyases; Dopamine beta-Hydroxylase; Heart; Immunoassay; Immunodiffusion; Kinetics; L-Lactate Dehydrogenase; Levodopa; Male; Methyldopa; Myocardium; Rats | 1979 |
Colorimetric enzymatic determination of serum total carbon dioxide, as applied to the Vickers Multichannel 300 discrete analyzer.
Topics: Acetoacetates; Aminosalicylic Acids; Animals; Ascorbic Acid; Autoanalysis; Bilirubin; Carbon Dioxide; Carboxy-Lyases; Edible Grain; Humans; Hydrogen-Ion Concentration; Isoniazid; Levodopa; Malate Dehydrogenase; Methyldopa; Myocardium; Oxaloacetates; Phosphoenolpyruvate; Pyruvates; Sulfathiazoles; Swine | 1975 |
[Pharmacology of several aromatic amino acid decarboxylase inhibitors].
Topics: 3,4-Dihydroxyphenylacetic Acid; 5-Hydroxytryptophan; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Drug Interactions; Indoles; Kidney; Lactates; Levodopa; Methyldopa; Phenylacetates; Rabbits | 1978 |
Effect of a catechol-O-methyl transferase inhibitor, U-0521, with levodopa administration.
Topics: Animals; Behavior, Animal; Brain; Catechol O-Methyltransferase Inhibitors; Dihydroxyphenylalanine; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Homovanillic Acid; Levodopa; Male; Methyldopa; Propiophenones; Rats; Time Factors | 1979 |
Levodopa and dopamine analogs: melanin precursors as antitumor agents in experimental human and murine leukemia.
Topics: Animals; Antineoplastic Agents; Cell Cycle; Cells, Cultured; Dopamine; Humans; Leukemia L1210; Leukemia, Experimental; Levodopa; Male; Methyldopa; Mice; Nervous System; Structure-Activity Relationship | 1979 |
Ultrastructure of thyroid C cells following long-term administration of 1-DOPA or alpha-methyl-DOPA.
Topics: Animals; Levodopa; Male; Methyldopa; Rats; Thyroid Gland; Time Factors | 1979 |
[Alphamethyldopa and levodopa interaction].
Topics: Aged; Drug Interactions; Female; Humans; Levodopa; Methyldopa; Parkinson Disease | 1979 |
New procedure for isolation of amino acids based on selective hydrolysis of trimethylsilyl derivatives.
Topics: Amino Acids; Gas Chromatography-Mass Spectrometry; Humans; Levodopa; Methyldopa; Trimethylsilyl Compounds; Tyrosine | 1979 |
Where is L-DOPA decarboxylated in the striatum after 6-hydroxydopamine nigrotomy?
Topics: Animals; Benserazide; Blood-Brain Barrier; Capillaries; Corpus Striatum; Decarboxylation; Dopamine; Endothelium; Female; Humans; Hydroxydopamines; Levodopa; Methyldopa; Premedication; Rats; Receptors, Dopamine; Stereotyped Behavior; Substantia Nigra | 1978 |
Plasma O-methyldopa in levodopa-induced dyskinesias. A bioclinical investigation.
Topics: Aged; Benserazide; Carbidopa; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Methyldopa; Middle Aged; Parkinson Disease | 1977 |
Applications of paired ion high-pressure liquid chromatography to catecholamines and phenylephrine.
Topics: Capsules; Catecholamines; Chromatography, High Pressure Liquid; Levodopa; Methods; Methyldopa; Phenylephrine; Solutions; Tablets | 1978 |
[Adaptation to the Centrifichem of the estimation of blood sugar according to Trinder's method. Kinetic study of the main drug interferences (author's transl)].
Topics: Ascorbic Acid; Blood Glucose; Centrifugation; Gentisates; Kinetics; Levodopa; Methyldopa | 1978 |
Does O-methyl-dopa play a role in levodopa-induced dyskinesias?
Topics: Adult; Aged; Benserazide; Carbidopa; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Methyldopa; Middle Aged; Parkinson Disease | 1977 |
Changes in sizes of the adrenaline-containing vesicles and their cores in frog cardiac sympathetic nerves after pharmacological treatments.
Topics: Animals; Anura; Autonomic Fibers, Postganglionic; Dopamine; Dose-Response Relationship, Drug; Epinephrine; Heart; Histocytochemistry; Hydroxydopamines; Levodopa; Male; Methyldopa; Methyltyrosines; Norepinephrine; Sympathetic Nervous System | 1977 |
Effect of L-DOPA analogues in Sidman avoidance performance in mice.
Topics: Animals; Avoidance Learning; Benserazide; Brain; Dihydroxyphenylalanine; Dopamine; Dose-Response Relationship, Drug; Levodopa; Male; Methyldopa; Mice; Motor Activity; Norepinephrine; Serotonin | 1977 |
Amphetamines, growth hormone and narcolepsy.
Topics: Adult; Aged; Amphetamine; Arousal; Clomipramine; Dextroamphetamine; Drug Interactions; Drug Tolerance; Female; Growth Hormone; Hemodynamics; Humans; Levodopa; Male; Methyldopa; Middle Aged; Narcolepsy; Time Factors | 1977 |
N-Acetyl, 4-O-methyldopa, a major metabolite of L-4-O-methyldopa in man and rat.
Topics: Acetylation; Adult; Animals; Dopamine; Female; Homovanillic Acid; Humans; Isomerism; Lactates; Levodopa; Male; Methyldopa; Pyruvates; Rats; Species Specificity | 1976 |
Piribedil: its synergistic effect in multidrug regimens for parkinsonism.
Topics: Aged; Amantadine; Drug Synergism; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Methyldopa; Middle Aged; Movement Disorders; Parasympatholytics; Parkinson Disease; Piperazines; Piribedil | 1976 |
A comparison of the effects of decarboxylase inhibitors on L-dopa-induced circling behavior and the conversion of dopa to dopamine in the brain.
Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Behavior, Animal; Benserazide; Brain; Brocresine; Carbidopa; Dopamine; Hydrazines; Levodopa; Male; Methyldopa; Rats; Time Factors | 1976 |
[Facilitation of the effects of L-DOPA by alpha-methyldopa].
Topics: Animals; Blood Pressure; Catalepsy; Cats; Dopamine; Drug Interactions; Drug Therapy, Combination; Haloperidol; Humans; Levodopa; Male; Methyldopa; Mice; Nictitating Membrane; Reserpine | 1976 |
Comparison of short and long-lasting effects of pargyline on cerebral dopamine metabolism.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Cisterna Magna; Corpus Striatum; Dopamine; Female; Homovanillic Acid; Injections; Injections, Intravenous; Levodopa; Methyldopa; Monoamine Oxidase; Pargyline; Rats; Time Factors; Tyrosine | 1976 |
3-O-methyldopa uptake and inhibition of L-dopa at the blood-brain barrier.
Topics: Animals; Biological Availability; Biological Transport, Active; Blood-Brain Barrier; Brain; Cerebral Cortex; Corpus Striatum; Diffusion; Hypothalamus; Kinetics; Levodopa; Male; Mesencephalon; Methyldopa; Parkinson Disease; Rats | 1975 |
Experimental studies on the pathogenesis and prophylaxis of stroke in stroke-prone spontaneously hypertensive rats (SHR). (2) Prophylactic effect of moderate control of blood pressure on stroke.
Topics: Animals; Carbidopa; Carboxy-Lyases; Cerebrovascular Disorders; Heart Rate; Hydralazine; Hypertension; Levodopa; Male; Methyldopa; Rats | 1975 |
Five years' treatment of Parkinson's disease with levodopa. Therapeutic results and survival of 100 patients.
Topics: Adult; Aged; Carbidopa; Female; Follow-Up Studies; Humans; Levodopa; Male; Methyldopa; Middle Aged; Parkinson Disease | 1975 |
Optical resolution of N-acyl-DL-amino acids by preferential crystallization procedure. Preparation of L-DOPA and L-alpha-methyl DOPA.
Topics: Crystallization; Levodopa; Methyldopa; Optical Rotation | 1975 |
Effects of chronic oral administration on the disposition of laevodopa and its major metabolites in the plasma of the rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Administration, Oral; Animals; Catecholamines; Homovanillic Acid; Levodopa; Male; Methyldopa; Rats; Time Factors; Vanilmandelic Acid | 1975 |
[Effect of alpha-methyldopa on the inhibition by L-dopa of the hypothalamo-hypophyseal-adrenocortical system during hypoglycemic stress in humans].
Topics: Adrenal Cortex; Adrenal Glands; Adult; Blood Glucose; Female; Humans; Hydrocortisone; Hypothalamus; Insulin; Levodopa; Male; Methyldopa; Pituitary Gland; Pituitary Gland, Anterior; Pituitary-Adrenal Function Tests | 1975 |
[Pharmacologic study of adrenergic mechanisms of compensatory hypertrophy of the ovary].
Topics: Animals; Castration; Chlorpromazine; Diethylstilbestrol; Disulfiram; Female; Follicle Stimulating Hormone; Levodopa; Methyldopa; Ovary; Phenytoin; Rats; Sympathetic Nervous System | 1975 |
The dopamine hypothesis of schizophrenia. A critical analysis.
Topics: Acetylcholine; Amphetamine; Apomorphine; Cocaine; Dopamine; Electroconvulsive Therapy; gamma-Aminobutyric Acid; Humans; Levodopa; Methyldopa; Methyltyrosines; Models, Neurological; Psychoses, Substance-Induced; Schizophrenia; Tranquilizing Agents | 1975 |
Medical modification of sensation.
Topics: Adult; Denervation; Differential Threshold; Female; Glossopharyngeal Nerve; Humans; Levodopa; Male; Methyldopa; Middle Aged; Neural Pathways; Pain, Intractable; Peripheral Nerves; Sensation; Spinal Nerve Roots; Trigeminal Nerve; Vagus Nerve | 1976 |
Effects of aging on LH and prolactin after LHRL L-dopa, methyl-dopa, and stress in male rat.
Topics: Aging; Animals; Hypothalamus; Levodopa; Luteinizing Hormone; Male; Methyldopa; Pituitary Gland, Anterior; Prolactin; Rats; Stress, Physiological | 1976 |
[Experiences in the treatment of Parkinsonism using a combination of L-dopa and alpha-methyldopa-hydrazine].
Topics: Adult; Aged; Drug Combinations; Drug Evaluation; Drug Synergism; Humans; Hydrazines; Levodopa; Methyldopa; Middle Aged; Parkinson Disease | 1976 |
Gout induced by L-dopa and decarboxylase inhibitors.
Topics: Aged; Carbidopa; Carboxy-Lyases; Gout; Humans; Levodopa; Male; Methyldopa; Middle Aged; Parkinson Disease | 1976 |
Different in vivo properties of three new inhibitors of catechol O-methyltransferase in the rat.
Topics: Amidines; Animals; Benzophenones; Biogenic Monoamines; Brain; Carbidopa; Catechol O-Methyltransferase Inhibitors; Catechols; Corpus Striatum; Homovanillic Acid; Hypothalamus; Levodopa; Male; Methyldopa; Nitriles; Nitrophenols; Pyridones; Rats; Rats, Inbred Strains; Tolcapone | 1992 |
High-performance liquid chromatography with electrochemical detection for the determination of levodopa, catecholamines and their metabolites in rat brain dialysates.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Chemistry; Catecholamines; Caudate Nucleus; Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; Dopamine; Epinephrine; Homovanillic Acid; Injections, Intraperitoneal; Levodopa; Male; Methyldopa; Norepinephrine; Rats; Rats, Inbred Strains; Substantia Nigra | 1992 |
Some parasympathetic neurons in the guinea-pig heart express aspects of the catecholaminergic phenotype in vivo.
Topics: Animals; Catecholamines; Dopamine; Dopamine beta-Hydroxylase; Female; Ganglia, Autonomic; Guinea Pigs; Heart; Immunohistochemistry; Levodopa; Male; Methyldopa; Neurons; Norepinephrine; Pargyline; Phenotype; Serotonin; Sympathectomy, Chemical; Tyrosine 3-Monooxygenase | 1990 |
The interaction of orally administered iron with levodopa and methyldopa therapy.
Topics: Administration, Oral; Drug Interactions; Ferric Compounds; Ferrous Compounds; Humans; Hydrogen-Ion Concentration; Levodopa; Methyldopa; Oxidation-Reduction; Spectrophotometry, Ultraviolet | 1990 |
Fully automated high-performance liquid chromatographic assay for the analysis of free catecholamines in urine.
Topics: Autoanalysis; Chromatography, High Pressure Liquid; Dopamine; Epinephrine; Humans; Hydrogen-Ion Concentration; Levodopa; Methyldopa; Norepinephrine; Quality Control | 1990 |
Coulometric determination of levodopa, methyldopa and carbidopa.
Topics: Azo Compounds; Carbidopa; Electrochemistry; Levodopa; Methyldopa | 1990 |
Magnitude of response to levodopa in Parkinson disease as it relates to peripheral and central measurements of levodopa and associated metabolites.
Topics: Aged; Carbidopa; Drug Combinations; Homovanillic Acid; Humans; Levodopa; Male; Methyldopa; Middle Aged; Parkinson Disease | 1989 |
Spectrophotometric determination of microquantities of Carbidopa, Levodopa and alpha-methyldopa using molybdatophosphoric acid.
Topics: Carbidopa; Levodopa; Methyldopa; Molybdenum; Phosphoric Acids; Spectrophotometry, Ultraviolet | 1989 |
Continuous oral administration of L-dihydroxyphenylalanine (L-DOPA) solution to patients with advanced Parkinson's disease.
Topics: Administration, Oral; Chromatography, High Pressure Liquid; Humans; Infusions, Intravenous; Injections, Intravenous; Levodopa; Methyldopa; Parkinson Disease | 1989 |
[Distribution of neurotensin-like immunoreactivity (NTLI) and neurotensin receptor in the rat brain and effects of various drugs on NTLI concentration and NT receptor in the rat cerebral cortex].
Topics: Animals; Brain; Cerebral Cortex; Dopamine; Haloperidol; In Vitro Techniques; Injections, Intraventricular; Levodopa; Male; Methyldopa; Neuropeptides; Rats; Receptors, Neurotensin; Receptors, Neurotransmitter | 1988 |
Pharmacokinetics of L-dopa in patients with Parkinson's disease.
Topics: Biotransformation; Carbidopa; Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; Disability Evaluation; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Humans; Kinetics; Levodopa; Methyldopa; Parkinson Disease; Receptors, Dopamine; Receptors, Dopamine D2; Tiapamil Hydrochloride | 1987 |
Inhibition of monoamine oxidase by 3,4-dihydroxyphenyl L-alanine and its analogues.
Topics: Dihydroxyphenylalanine; Droxidopa; Humans; In Vitro Techniques; Kynuramine; Levodopa; Methyldopa; Mitochondria; Mitochondria, Liver; Monoamine Oxidase Inhibitors; Placenta; Stereoisomerism; Structure-Activity Relationship | 1987 |
Repeated levodopa infusions in fluctuating Parkinson's disease: clinical and pharmacokinetic data.
Topics: Drug Administration Schedule; Drug Interactions; Female; Humans; Infusions, Parenteral; Kinetics; Levodopa; Male; Methyldopa; Middle Aged; Parkinson Disease; Time Factors | 1986 |
Pharmacokinetics of levodopa and motor fluctuations.
Topics: Administration, Oral; Chromatography, High Pressure Liquid; Humans; Infusions, Intravenous; Kinetics; Levodopa; Methyldopa; Motor Skills; Parkinson Disease | 1987 |
The effect of L-DOPA on brain polysomes and protein synthesis: probable mediation by intracellular dopamine.
Topics: 5-Hydroxytryptophan; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Brain; Carbon Radioisotopes; Decarboxylation; Depression, Chemical; Dihydroxyphenylalanine; Dopamine; Drug Interactions; Enzyme Inhibitors; Hydrazines; Leucine; Levodopa; Lysine; Male; Methyldopa; Nerve Tissue Proteins; Norepinephrine; Polyribosomes; Rats; S-Adenosylmethionine; Time Factors | 1974 |
[The determination of bilirubin as azobilirubin in plasma and serum with the Greiner electronic selective analyzer GSA II (author's transl)].
Topics: Ascorbic Acid; Azo Compounds; Bilirubin; Chemistry, Clinical; Diazonium Compounds; Epinephrine; Hemoglobins; Hemolysis; Histidine; Humans; Hyperlipidemias; Levodopa; Methyldopa; Norepinephrine; Rifampin; Spectrophotometry, Ultraviolet; Statistics as Topic; Tyrosine | 1974 |
The effects of L-dopa and alpha-methyldopa on reflexes and sympathetic nerve function.
Topics: Animals; Atropine; Barbiturates; Benserazide; Blood Pressure; Carbidopa; Carotid Arteries; Dogs; Electric Stimulation; Heart Rate; Hindlimb; Levodopa; Methyldopa; Monoamine Oxidase Inhibitors; Neurons; Perfusion; Posture; Reflex; Regional Blood Flow; Sympathetic Nervous System; Vagotomy; Vagus Nerve | 1974 |
3-O-Methyldopa in Parkinson's disease.
Topics: Antiparkinson Agents; Drug Antagonism; Drug Therapy, Combination; Humans; Levodopa; Methyldopa; Parkinson Disease; Time Factors; Trihexyphenidyl | 1974 |
The "on-off" response to chronic L-DOPA treatment of Parkinsonism.
Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Confusion; Dietary Proteins; Enzyme Inhibitors; Female; Gait; Humans; Levodopa; Male; Methyldopa; Movement Disorders; Muscle Cramp; Parkinson Disease; Time Factors | 1974 |
Effect of L-DOPA and analogues on central dopamine and noradrenaline mechanisms.
Topics: 5-Hydroxytryptophan; Acetamides; Animals; Apomorphine; Brain Chemistry; Clonidine; Corpus Striatum; Dopamine; Hydrazines; Levodopa; Methyldopa; Methyltyrosines; Movement; Nialamide; Norepinephrine; Octopamine; Rats; Receptors, Drug; Reflex; Reserpine; Spinal Cord; Stimulation, Chemical; Tyramine; Tyrosine | 1974 |
Effects of 3,4-dihydroxyphenylpyruvic acid and L-glutamic acid on some pharmacokinetic parameters of L-dopa in the rat.
Topics: Animals; Biological Availability; Brain Chemistry; Dopamine; Drug Interactions; Glutamates; Homovanillic Acid; Kinetics; Levodopa; Male; Methyldopa; Motor Activity; Phenylpyruvic Acids; Rats | 1980 |
[Catecholaminergic neuronal pathways in homeostatic control of blood circulating mass].
Topics: Adrenergic alpha-Antagonists; Animals; Benserazide; Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide; Diuresis; Levodopa; Methyldopa; Phentolamine; Rats; Thirst | 1980 |
Effect of 1-DOPA on calcitonin secretion by thyroid C cells.
Topics: Animals; APUD Cells; Calcitonin; Calcium Gluconate; Cytoplasmic Granules; Guinea Pigs; Levodopa; Methyldopa; Microscopy, Electron; Rats; Thyroid Gland | 1983 |
Catechol-O-methyltransferase and Parkinson's disease.
Topics: Animals; Brain; Catechol O-Methyltransferase; Corpus Striatum; Levodopa; Male; Methyldopa; Parkinson Disease; Propiophenones; Rats; Rats, Inbred Strains | 1984 |
"On-off" phenomenon in Parkinson's disease.
Topics: Animals; Carbidopa; Humans; Levodopa; Methyldopa; Parkinson Disease | 1984 |
Determination of the enantiomeric purity of levodopa, methyldopa, carbidopa and tryptophan by use of chiral mobile phase high-performance liquid chromatography.
Topics: Capsules; Carbidopa; Chromatography, High Pressure Liquid; Copper; Copper Sulfate; Drug Contamination; Levodopa; Methyldopa; Phenylalanine; Stereoisomerism; Tablets; Tryptophan | 1983 |
Influence of carbidopa, an aromatic amino acid decarboxylase inhibitor, on the development of autoimmune hemolytic anemia in NZB mice.
Topics: Anemia, Hemolytic, Autoimmune; Animals; Body Weight; Carbidopa; Coombs Test; Female; Hematocrit; Levodopa; Male; Methyldopa; Mice; Mice, Inbred NZB | 1983 |
Endogenous dopamine synthesis and dopa-decarboxylase activity in rat renal cortex.
Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Aromatic-L-Amino-Acid Decarboxylases; Dopa Decarboxylase; Dopamine; Kidney Cortex; Kidney Glomerulus; Kinetics; Levodopa; Male; Methyldopa; Rats; Rats, Inbred Strains | 1982 |
Catechol-O-methyltransferase inhibition by U-0521 increases striatal utilization of levodopa.
Topics: Animals; Catechol O-Methyltransferase Inhibitors; Catecholamines; Corpus Striatum; Dose-Response Relationship, Drug; Levodopa; Male; Methyldopa; Propiophenones; Rats; Rats, Inbred Strains; Time Factors | 1982 |
Alpha-Monofluoromethyldopa (MFMD) in combination with L-DOPA Effects on tissue catecholamines and blood pressure in rats.
Topics: Animals; Blood Pressure; Catecholamines; Drug Interactions; Levodopa; Male; Methyldopa; Rats; Rats, Inbred Strains; Sodium Chloride | 1982 |
[Catecholamines in the mechanism of the cardionecrotic action of acetaldehyde].
Topics: Acetaldehyde; Animals; Catecholamines; Drug Synergism; Epinephrine; Heart; In Vitro Techniques; Levodopa; Male; Methyldopa; Methyltyrosines; Necrosis; Rats | 1982 |
Catechol-O-methyltransferase activity: a determinant of levodopa response.
Topics: Aged; Catechol O-Methyltransferase; Catechol O-Methyltransferase Inhibitors; Erythrocytes; Female; Humans; Kidney; Levodopa; Liver; Male; Methyldopa; Middle Aged; Parkinson Disease; Time Factors | 1980 |
Irreversible inhibition of aromatic-L-amino acid decarboxylase by alpha-difluoromethyl-DOPA and metabolism of the inhibitor.
Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Catechol O-Methyltransferase; Dihydroxyphenylalanine; Kidney; Levodopa; Methylation; Methyldopa; Pyridoxal Phosphate; Rats; Swine | 1980 |
Quantitative microdialysis for studying the in vivo L-DOPA kinetics in blood and skeletal muscle of the dog.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Blood Proteins; Calibration; Dialysis; Dogs; Dopamine; Injections, Intramuscular; Injections, Intravenous; Levodopa; Male; Methyldopa; Microchemistry; Muscle, Skeletal; Protein Binding; Reference Standards; Reproducibility of Results; Tyrosine | 1995 |
Early L-dopa treatment initially retards but later enhances dopamine receptor supersensitivity following unilateral dopamine denervation.
Topics: Animals; Behavior, Animal; Denervation; Functional Laterality; Homovanillic Acid; Levodopa; Male; Methyldopa; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Rotation; Time Factors | 1994 |
3-O-methyl-DOPA is not involved in the development of behavioral supersensitivity after repeated L-dopa administration in 6-OHDA lesioned rats.
Topics: Animals; Apomorphine; Carbidopa; Catechol O-Methyltransferase Inhibitors; Corpus Striatum; Levodopa; Male; Methyldopa; Motor Activity; Oxidopamine; Rats; Rats, Wistar; Receptors, Dopamine; Stereotyped Behavior; Substantia Nigra | 1994 |
The effect of pH on the suicide inactivation of frog epidermis tyrosinase.
Topics: Animals; Catechols; Enzyme Stability; Epidermis; Hydrogen-Ion Concentration; Kinetics; Levodopa; Methyldopa; Models, Biological; Monophenol Monooxygenase; Ranidae | 1994 |
Black cartilage after therapy with levodopa and methyldopa.
Topics: Aged; Aged, 80 and over; Cartilage, Articular; Dose-Response Relationship, Drug; Female; Humans; Intervertebral Disc; Levodopa; Male; Methyldopa; Microscopy, Electron; Parkinson Disease; Pigmentation; Ribs; Time Factors | 1994 |
Immunogenicity studies of a synthetic antigen of alpha methyl dopa.
Topics: Animals; Antibody Formation; Antigens; Autoantibodies; Autoimmunity; Catechols; Haptens; Immunization; Levodopa; Liver; Male; Methyldopa; Rabbits; Serum Albumin | 1993 |
Simultaneous monitoring of levodopa, dopamine and their metabolites in skeletal muscle and subcutaneous tissue in different pharmacological conditions using microdialysis.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Carbidopa; Chromatography, High Pressure Liquid; Dialysis; Dogs; Dopamine; Electrochemistry; Extracellular Space; Injections, Intravenous; Levodopa; Male; Methyldopa; Muscles; Skin | 1993 |
Circadian phase dependent pharmacokinetics of L-dopa, its main metabolites (3-OMD, HVA, DOPAC) and carbidopa in rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Area Under Curve; Carbidopa; Circadian Rhythm; Half-Life; Homovanillic Acid; Levodopa; Male; Methyldopa; Rats; Rats, Wistar | 1996 |
Automated determination of levodopa and carbidopa in plasma by high-performance liquid chromatography-electrochemical detection using an on-line flow injection analysis sample pretreatment unit.
Topics: Animals; Antiparkinson Agents; Automation; Carbidopa; Chromatography, High Pressure Liquid; Dogs; Electrochemistry; Flow Injection Analysis; Levodopa; Male; Methyldopa; Reference Standards | 1997 |
Direct high-performance liquid chromatographic determination of the enantiomeric purity of levodopa and methyldopa: comparison with pharmacopoeial polarimetric methods.
Topics: Chromatography, High Pressure Liquid; Czech Republic; Europe; Evaluation Studies as Topic; Levodopa; Ligands; Methyldopa; Optical Rotation; Pharmacopoeias as Topic; Reproducibility of Results; Sensitivity and Specificity; Solvents; Stereoisomerism; Teicoplanin | 1999 |
Pharmacogenetics of catechol-O-methyltransferase: frequency of low activity allele in a Ghanaian population.
Topics: Adolescent; Adult; Alleles; Asia, Western; Catechol O-Methyltransferase; Enzyme Activation; Female; Gene Frequency; Ghana; Humans; Kenya; Levodopa; Male; Methyldopa; Middle Aged | 2000 |
Effect of alpha-methyldopa on pentoxyresorufin O-dealkylation in liver microsomes from rats treated with phenobarbital.
Topics: Animals; Ascorbic Acid; Cytochrome P-450 CYP2B1; Cytochrome P-450 CYP2E1 Inhibitors; Dopamine; Enzyme Inhibitors; Glutathione; Levodopa; Lipid Peroxidation; Male; Methyldopa; Microsomes, Liver; NADP; Oxazines; Phenobarbital; Rats; Rats, Wistar | 2001 |
Brain catecholamine metabolism in catechol-O-methyltransferase (COMT)-deficient mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Anesthesia; Animals; Carbidopa; Catechol O-Methyltransferase; Corpus Striatum; Dopamine; Dopamine Agents; Female; Homovanillic Acid; Levodopa; Male; Methoxyhydroxyphenylglycol; Methyldopa; Mice; Mice, Inbred C57BL; Mice, Knockout; Microdialysis; Norepinephrine | 2002 |
Binding site of salsolinol: its properties in different regions of the brain and the pituitary gland of the rat.
Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Aromatic-L-Amino-Acid Decarboxylases; Benserazide; Binding Sites; Binding, Competitive; Brain; Carbidopa; Clonidine; Corpus Striatum; Dopamine; Dopamine Agonists; Dopamine Antagonists; Enzyme Inhibitors; Female; Isoquinolines; Kinetics; Lactation; Levodopa; Male; Mazindol; Median Eminence; Methyldopa; Pituitary Gland; Pituitary Gland, Posterior; Prolactin; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Reserpine | 2003 |
Analysis of L-dopa in human serum.
Topics: Antiparkinson Agents; Chromatography, Affinity; Edetic Acid; Formates; Humans; Hydrogen-Ion Concentration; Levodopa; Methyldopa; Parkinson Disease; Reference Standards | 2002 |
Catechol-O-methyltransferase inhibition in erythrocytes and liver by BIA 3-202 (1-[3,4-dibydroxy-5-nitrophenyl]-2-phenyl-ethanone).
Topics: Acetophenones; Administration, Oral; Animals; Antiparkinson Agents; Benserazide; Catechol O-Methyltransferase; Catechol O-Methyltransferase Inhibitors; Chromatography, High Pressure Liquid; Corpus Striatum; Dihydroxyphenylalanine; Drug Interactions; Erythrocytes; Humans; In Vitro Techniques; Levodopa; Liver; Methylation; Methyldopa; Microdialysis; Rats; Rats, Wistar | 2003 |
[ACTION OF CERTAIN L-DOPA/5-HTP DECARBOXYLASE INHIBITORS ON HYPOTHALAMO-HYPOPHYIAL NEUROSECRETION IN THE RAT].
Topics: 5-Hydroxytryptophan; Acetylcholine; Aromatic Amino Acid Decarboxylase Inhibitors; Carboxy-Lyases; Cinnamates; Dopa Decarboxylase; Enzyme Inhibitors; Hypothalamo-Hypophyseal System; Levodopa; Methyldopa; Neurosecretion; Pharmacology; Piperidines; Rats; Research; Serotonin | 1964 |
Mediated exodus of L-dopa from human epidermal Langerhans cells.
Topics: Adult; Amino Acids; Biological Transport; Biopsy; Epidermal Cells; Epidermis; Humans; Langerhans Cells; Levodopa; Methyldopa; Time Factors | 2004 |
Altered serotonin synthesis, turnover and dynamic regulation in multiple brain regions of mice lacking the serotonin transporter.
Topics: Animals; Aorta; Blotting, Northern; Brain; Chromatography, High Pressure Liquid; Dopamine; Female; Gene Expression Regulation; Hydroxyindoleacetic Acid; Kidney; Levodopa; Liver; Lung; Male; Methyldopa; Mice; Mice, Inbred C57BL; Mice, Knockout; Models, Biological; Myocardium; Nonlinear Dynamics; Norethandrolone; Pancreas; RNA, Messenger; Serotonin; Serotonin Plasma Membrane Transport Proteins; Sex Factors; Spleen; Time Factors; Tryptophan Hydroxylase | 2005 |
Comparative analysis of Cryptococcus neoformans acid-resistant particles generated from pigmented cells grown in different laccase substrates.
Topics: Chromatography, High Pressure Liquid; Cryptococcus neoformans; Cytoplasmic Granules; Electron Spin Resonance Spectroscopy; Epinephrine; Levodopa; Melanins; Methyldopa; Microscopy, Electron, Transmission; Norepinephrine; Organelles; Pigments, Biological | 2005 |
Evidence for L-dopa incorporation into cell proteins in patients treated with levodopa.
Topics: Aged; Antiparkinson Agents; Chromatography, High Pressure Liquid; Erythrocytes; Female; Humans; Hydrolysis; Levodopa; Lymphocytes; Male; Methyldopa; Parkinson Disease; Proteins | 2006 |
Simultaneous kinetic-spectrophotometric determination of carbidopa, levodopa and methyldopa in the presence of citrate with the aid of multivariate calibration and artificial neural networks.
Topics: Calibration; Carbidopa; Citric Acid; Humans; Hydrogen-Ion Concentration; Kinetics; Levodopa; Methyldopa; Neural Networks, Computer; Spectrophotometry | 2007 |
Quantitative analysis of levodopa, carbidopa and methyldopa in human plasma samples using HPLC-DAD combined with second-order calibration based on alternating trilinear decomposition algorithm.
Topics: Algorithms; Calibration; Carbidopa; Chemistry Techniques, Analytical; Chromatography; Chromatography, High Pressure Liquid; Humans; Levodopa; Methyldopa; Models, Chemical; Reproducibility of Results; Solvents | 2010 |
The timing of administration, dose dependence and efficacy of dopa decarboxylase inhibitors on the reversal of motor disability produced by L-DOPA in the MPTP-treated common marmoset.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Callithrix; Carbidopa; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Enzyme Inhibitors; Female; Levodopa; Male; Methyldopa; Motor Activity; Movement Disorders | 2010 |
Levodopa and 3-OMD levels in Parkinson patients treated with Duodopa.
Topics: Antiparkinson Agents; Drug Therapy, Combination; Duodenum; Female; Home Infusion Therapy; Homocysteine; Humans; Infusions, Parenteral; Levodopa; Male; Methyldopa; Parkinson Disease | 2010 |
Determination of L-dopa, carbidopa, 3-O-methyldopa and entacapone in human plasma by HPLC-ED.
Topics: Antiparkinson Agents; Calibration; Carbidopa; Catechols; Chromatography, High Pressure Liquid; Drug Combinations; Humans; Levodopa; Methyldopa; Nitriles; Reproducibility of Results; Solid Phase Extraction | 2011 |
Simultaneous quantitation of levodopa and 3-O-methyldopa in human plasma by HPLC-ESI-MS/MS: application for a pharmacokinetic study with a levodopa/benserazide formulation.
Topics: Benserazide; Calibration; Chromatography, High Pressure Liquid; Humans; Levodopa; Methyldopa; Quality Control; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Tablets; Tandem Mass Spectrometry | 2011 |
Development and validation of a high-performance liquid chromatography-electrospray ionization-MS/MS method for the simultaneous quantitation of levodopa and carbidopa in human plasma.
Topics: Administration, Oral; Carbidopa; Chromatography, High Pressure Liquid; Drug Stability; Female; Humans; Levodopa; Male; Methyldopa; Reproducibility of Results; Sensitivity and Specificity; Tablets; Tandem Mass Spectrometry | 2011 |
Cyclooxygenase-independent neuroprotective effects of aspirin against dopamine quinone-induced neurotoxicity.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Aspirin; Cell-Free System; Cells, Cultured; Cyclooxygenase Inhibitors; Dopamine Agents; Dopaminergic Neurons; Glutathione; Indomethacin; Levodopa; Meloxicam; Methyldopa; Mice; Neurons; Neuroprotective Agents; Quinones; Sympatholytics; Thiazines; Thiazoles | 2012 |
Dopamine replacement modulates oscillatory coupling between premotor and motor cortical areas in Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Bayes Theorem; Brain Waves; Case-Control Studies; Deep Brain Stimulation; Electroencephalography; Electromyography; Female; Fourier Analysis; Humans; Image Processing, Computer-Assisted; Levodopa; Magnetic Resonance Imaging; Male; Methyldopa; Middle Aged; Motor Cortex; Muscle, Skeletal; Neural Pathways; Oxygen; Parkinson Disease; Time Factors | 2014 |
Levodopa-related cysteinyl-glycine and cysteine reduction with and without catechol-O-methyltransferase inhibition in Parkinson's disease patients.
Topics: Aged; Analysis of Variance; Antiparkinson Agents; Carbidopa; Catechol O-Methyltransferase; Catechols; Chromatography, Reverse-Phase; Cysteine; Dipeptides; Drug Delivery Systems; Female; Humans; Levodopa; Male; Methyldopa; Middle Aged; Nitriles; Parkinson Disease; Time Factors | 2014 |